RepliCel

RepliCel Life Sciences is a Canadian regenerative medicine company based in Vancouver, British Columbia.[1] The company focuses on development of cell therapies using a patient's own cells (autologous cell therapy).[1] The company has treatment development activities targeting chronic tendon injuries which have failed to heal properly,[3] and hair restoration.[2] The company's expertise lies in isolation and exploitation of different cell populations found in the human hair follicle.[1]

RepliCel Life Sciences Inc.
Founder
  • Rolf Hoffmann
  • Kevin McElwee
Headquarters
Vancouver, British Columbia
,
Canada
Key people
  • David Hall (CEO)
Number of employees
15 FTE (2015)
Websitewww.replicel.com
Footnotes / references
[1][2]

The company's business model is focused on establishing proof-of-concept for treatments leading to acquisition by a larger company.[2] An alternative business model has been reported which does not involve acquisition but rather partnership where technologies and methods are licensed to a partner which will commercialize them.[1]

References
  1. Dutton, Gail (15 April 2015). "Cell Therapy Is "Hair Raising" in a Good Way". Genetic Engineering & Biotechnology News. 35 (8): 8–9. Retrieved 16 July 2016.
  2. Ellis, Erin (30 October 2013). "A cure for baldness? Stem cell researchers race to regenerate follicles from hair resistant to loss". National Post. Toronto. Retrieved 2016-07-15.
  3. Ilic, Dusko (September 2013). "Industry Update: Latest developments in stem cell research and regenerative medicine". Regenerative Medicine. 8 (5). RepliCel. doi:10.2217/rme.13.56.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.